GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Zhejiang Cheng Yi Pharmaceutical Co Ltd (SHSE:603811) » Definitions » Cash, Cash Equivalents, Marketable Securities

Zhejiang Cheng Yi Pharmaceutical Co (SHSE:603811) Cash, Cash Equivalents, Marketable Securities : ¥172.7 Mil (As of Mar. 2025)


View and export this data going back to 2017. Start your Free Trial

What is Zhejiang Cheng Yi Pharmaceutical Co Cash, Cash Equivalents, Marketable Securities?

Zhejiang Cheng Yi Pharmaceutical Co's quarterly cash, cash equivalents, marketable securities declined from Sep. 2024 (¥207.91 Mil) to Dec. 2024 (¥173.04 Mil) but then stayed the same from Dec. 2024 (¥173.04 Mil) to Mar. 2025 (¥172.68 Mil).

Zhejiang Cheng Yi Pharmaceutical Co's annual cash, cash equivalents, marketable securities increased from Dec. 2022 (¥213.51 Mil) to Dec. 2023 (¥294.14 Mil) but then declined from Dec. 2023 (¥294.14 Mil) to Dec. 2024 (¥173.04 Mil).


Zhejiang Cheng Yi Pharmaceutical Co Cash, Cash Equivalents, Marketable Securities Historical Data

The historical data trend for Zhejiang Cheng Yi Pharmaceutical Co's Cash, Cash Equivalents, Marketable Securities can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Zhejiang Cheng Yi Pharmaceutical Co Cash, Cash Equivalents, Marketable Securities Chart

Zhejiang Cheng Yi Pharmaceutical Co Annual Data
Trend Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24
Cash, Cash Equivalents, Marketable Securities
Get a 7-Day Free Trial Premium Member Only Premium Member Only 72.31 83.32 213.51 294.14 173.04

Zhejiang Cheng Yi Pharmaceutical Co Quarterly Data
Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25
Cash, Cash Equivalents, Marketable Securities Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 251.96 177.18 207.91 173.04 172.68

Zhejiang Cheng Yi Pharmaceutical Co Cash, Cash Equivalents, Marketable Securities Calculation

Cash and cash equivalents are the most liquid assets on the balance sheet. Cash equivalents are assets that are readily convertible into cash, such as money market holdings, short-term government bonds or Treasury bills, marketable securities and commercial paper.

Marketable Securities are very liquid securities that can be converted into cash quickly at a reasonable price.


Zhejiang Cheng Yi Pharmaceutical Co  (SHSE:603811) Cash, Cash Equivalents, Marketable Securities Explanation

Marketable securities are very liquid as they tend to have maturities of less than one year. Furthermore, the rate at which these securities can be bought or sold has little effect on their prices.

A high number means either:

1) The company has competitive advantage generating lots of cash

2) Just sold a business or bonds (not necessarily good)

A low stockpile of cash usually means poor to mediocre economics.

There are 3 ways to create large cash reserve.

1) Sell new bonds or equity to public

2) Sell business or asset

3) It has an ongoing business generating more cash than it burns (usually means durable competitive advantage)

When a company is suffering a short term problem, Buffett looks at cash or marketable securities to see whether it has the financial strength to ride it out.

Important: Lots of cash and marketable securities + little debt = good chance that the business will sail on through tough times.

Test to see what is creating cash by looking at past 7 yrs of balance sheets. This will reveal how the cash was created.


Zhejiang Cheng Yi Pharmaceutical Co Cash, Cash Equivalents, Marketable Securities Related Terms

Thank you for viewing the detailed overview of Zhejiang Cheng Yi Pharmaceutical Co's Cash, Cash Equivalents, Marketable Securities provided by GuruFocus.com. Please click on the following links to see related term pages.


Zhejiang Cheng Yi Pharmaceutical Co Business Description

Traded in Other Exchanges
N/A
Address
Lane 988, Shenhong Road, 7th Floor, No. 9, Building 20, Fuli Yuedu, Minhang District, Shanghai, CHN, 201100
Zhejiang Cheng Yi Pharmaceutical Co Ltd is a pharmaceutical company that produces capsules, injections, tablets, APIs, and pharmaceutical intermediates in China. Its main products include glucosamine hydrochloride raw materials and preparations, torasemide injection and capsules, Gastrodin raw materials, ribavirin and purine raw materials, and so on.
Executives
Ke Ze Hui Director
Ren Bing Jun Director
Yan Yi Yi Director
Ceng Huan Qun Director
Li Shi Sheng Director
Qiu Ke Rong Director
Lv Sun Zhan senior management
Zhang Gao Qiao Supervisors
Zhang Zhi Hong senior management
Mao Li Ping senior management
Zhuang Xiao Ping Director
Lin Xin Chen senior management
Shen Ai Lan Director
Zhang Fu Fu Supervisors

Zhejiang Cheng Yi Pharmaceutical Co Headlines

No Headlines